Showing results (221-230 of 294) with videos related to
Sort By:
Pageof 30
Diagnostics (Basel, Switzerland)|June 2, 2021
A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory StudyValentina D A Corino, Marco Bologna, Giuseppina Calareso, et al.Critical Reviews in Oncology/Hematology|July 19, 2015
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensusElvio G Russi, Francesco Moretto, Monica Rampino, et al.Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.Oral Oncology|May 26, 2025
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2Paolo Rondi, Davide Mattavelli, Vittorio Rampinelli, et al.Endocrine-Related Cancer|January 5, 2018
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patientsPaola Romeo, Carla Colombo, Roberta Granata, et al.Cancers|October 17, 2020
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma PatientsMarco Bologna, Valentina Corino, Giuseppina Calareso, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2021
Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid CancerLori J Wirth, Marcia S Brose, Eric J Sherman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]J Simon W Stewart, Ezra E W Cohen, Lisa Licitra, et al.Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.Oral Oncology|October 1, 2023
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experienceStefano Cavalieri, Francesca Platini, Francesco Barretta, et al.Pageof 30